-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, V1a5XGWLWCPdM+1nqYZgYtAuwOdbFBZXEfIQ1bqOjiPUFu8KqIiteh8bMzXjeUE5 U41vbD5L3d6v74EYw2DdDw== 0000950123-11-013179.txt : 20110214 0000950123-11-013179.hdr.sgml : 20110214 20110214072956 ACCESSION NUMBER: 0000950123-11-013179 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20110214 DATE AS OF CHANGE: 20110214 GROUP MEMBERS: HOVE, ANDERS GROUP MEMBERS: ROBERTS, BRYAN GROUP MEMBERS: VENROCK CO-INVESTMENT HOLDINGS, LLC GROUP MEMBERS: VHCP MANAGEMENT, LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Chelsea Therapeutics International, Ltd. CENTRAL INDEX KEY: 0001333763 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203174202 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-81457 FILM NUMBER: 11602163 BUSINESS ADDRESS: STREET 1: 3530 TORINGDON WAY STREET 2: SUITE 200 CITY: CHARLOTTE STATE: NC ZIP: 28277 BUSINESS PHONE: 704-341-1516 MAIL ADDRESS: STREET 1: 3530 TORINGDON WAY STREET 2: SUITE 200 CITY: CHARLOTTE STATE: NC ZIP: 28277 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: VENROCK HEALTHCARE CAPITAL PARTNERS LP CENTRAL INDEX KEY: 0001458177 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 3340 HILLVIEW AVENUE CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-561-9580 MAIL ADDRESS: STREET 1: 3340 HILLVIEW AVENUE CITY: PALO ALTO STATE: CA ZIP: 94306 SC 13G/A 1 w81465sc13gza.htm SC 13G/A sc13gza
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G/A
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
CHELSEA THERAPEUTICS INTERNATIONAL, LTD.
(Name of Issuer)
COMMON STOCK
(Title of Class of Securities)
163428105
(CUSIP Number)
December 31, 2010
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
  o   Rule 13d-1(b)
 
  þ   Rule 13d-1(c)
 
  o   Rule 13d-1(d)
 
*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 

 


 

                     
CUSIP No.
 
163428105 
 

 

           
1   NAMES OF REPORTING PERSONS
Venrock Healthcare Capital Partners, L.P.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   þ1
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   4,864,2342
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    4,864,2342
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  4,864,2342
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
 
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  9.9 %3
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN
1       Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, VHCP Management, LLC, Anders Hove and Bryan Roberts are members of a group for the purposes of this Schedule 13G/A.
2      Consists of 3,024,253 shares of common stock and warrants to purchase 1,087,780 shares of common stock owned by Venrock Healthcare Capital Partners, L.P. and 553,217 shares of common stock and warrants to purchase 198,984 shares of common stock owned by VHCP Co-Investment Holdings, LLC. This represents the number of shares of the Issuer’s common stock beneficially owned as of December 31, 2010. Between December 31, 2010 and the date of the filing of this Schedule 13G/A, Venrock Healthcare Capital Partners, L.P. and VHCP Co-Investment Holdings, LLC have acquired additional shares of the Issuer’s common stock. As of the date of the filing of this Schedule 13G/A, the Reporting Persons beneficially own an aggregate of 5,189,934 shares of the Issuer’s common stock, representing 10.6% of the outstanding shares.
3      This percentage is calculated based upon 49,125,545 shares of the Issuer’s common stock outstanding as of October 29, 2010, as set forth in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 1, 2010.

Page 2 of 12


 

                     
CUSIP No.
 
163428105 
 

 

           
1   NAMES OF REPORTING PERSONS
VHCP Co-Investment Holdings, LLC
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   þ1
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   4,864,2342
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    4,864,2342
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  4,864,2342
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
 
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  9.9 %3
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  OO
1       Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, VHCP Management, LLC, Anders Hove and Bryan Roberts are members of a group for the purposes of this Schedule 13G/A.
2      Consists of 3,024,253 shares of common stock and warrants to purchase 1,087,780 shares of common stock owned by Venrock Healthcare Capital Partners, L.P. and 553,217 shares of common stock and warrants to purchase 198,984 shares of common stock owned by VHCP Co-Investment Holdings, LLC. This represents the number of shares of the Issuer’s common stock beneficially owned as of December 31, 2010. Between December 31, 2010 and the date of the filing of this Schedule 13G/A, Venrock Healthcare Capital Partners, L.P. and VHCP Co-Investment Holdings, LLC have acquired additional shares of the Issuer’s common stock. As of the date of the filing of this Schedule 13G/A, the Reporting Persons beneficially own an aggregate of 5,189,934 shares of the Issuer’s common stock, representing 10.6% of the outstanding shares.
3      This percentage is calculated based upon 49,125,545 shares of the Issuer’s common stock outstanding as of October 29, 2010, as set forth in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 1, 2010.

Page 3 of 12


 

                     
CUSIP No.
 
163428105 
 

 

           
1   NAMES OF REPORTING PERSONS
VHCP Management, LLC
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   þ1
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   4,864,2342
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    4,864,2342
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  4,864,2342
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
 
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  9.9 %3
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  OO
1       Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, VHCP Management, LLC, Anders Hove and Bryan Roberts are members of a group for the purposes of this Schedule 13G/A.
2       Consists of 3,024,253 shares of common stock and warrants to purchase 1,087,780 shares of common stock owned by Venrock Healthcare Capital Partners, L.P. and 553,217 shares of common stock and warrants to purchase 198,984 shares of common stock owned by VHCP Co-Investment Holdings, LLC. VHCP Management, LLC is the general partner of Venrock Healthcare Capital Partners, L.P. and the manager of VHCP Co-Investment Holdings, LLC. This represents the number of shares of the Issuer’s common stock beneficially owned as of December 31, 2010. Between December 31, 2010 and the date of the filing of this Schedule 13G/A, Venrock Healthcare Capital Partners, L.P. and VHCP Co-Investment Holdings, LLC have acquired additional shares of the Issuer’s common stock. As of the date of the filing of this Schedule 13G/A, the Reporting Persons beneficially own an aggregate of 5,189,934 shares of the Issuer’s common stock, representing 10.6% of the outstanding shares.
3       This percentage is calculated based upon 49,125,545 shares of the Issuer’s common stock outstanding as of October 29, 2010, as set forth in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 1, 2010.

Page 4 of 12


 

                     
CUSIP No.
 
163428105 
 

 

           
1   NAMES OF REPORTING PERSONS
Hove, Anders
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   þ1
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   4,864,2342
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    4,864,2342
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  4,864,2342
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
 
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  9.9 %3
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN
1       Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, VHCP Management, LLC, Anders Hove and Bryan Roberts are members of a group for the purposes of this Schedule 13G/A.
2       Consists of 3,024,253 shares of common stock and warrants to purchase 1,087,780 shares of common stock owned by Venrock Healthcare Capital Partners, L.P. and 553,217 shares of common stock and warrants to purchase 198,984 shares of common stock owned by VHCP Co-Investment Holdings, LLC. VHCP Management, LLC is the general partner of Venrock Healthcare Capital Partners, L.P. and the manager of VHCP Co-Investment Holdings, LLC. This represents the number of shares of the Issuer’s common stock beneficially owned as of December 31, 2010. Between December 31, 2010 and the date of the filing of this Schedule 13G/A, Venrock Healthcare Capital Partners, L.P. and VHCP Co-Investment Holdings, LLC have acquired additional shares of the Issuer’s common stock. As of the date of the filing of this Schedule 13G/A, the Reporting Persons beneficially own an aggregate of 5,189,934 shares of the Issuer’s common stock, representing 10.6% of the outstanding shares.
3       This percentage is calculated based upon 49,125,545 shares of the Issuer’s common stock outstanding as of October 29, 2010, as set forth in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 1, 2010.

Page 5 of 12


 

                     
CUSIP No.
 
163428105 
 

 

           
1   NAMES OF REPORTING PERSONS
Roberts, Bryan
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   þ1
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   4,864,2342
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    4,864,2342
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  4,864,2342
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
 
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  9.9 %3
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN
1       Venrock Healthcare Capital Partners, L.P., VHCP Co-Investment Holdings, LLC, VHCP Management, LLC, Anders Hove and Bryan Roberts are members of a group for the purposes of this Schedule 13G/A.
2       Consists of 3,024,253 shares of common stock and warrants to purchase 1,087,780 shares of common stock owned by Venrock Healthcare Capital Partners, L.P. and 553,217 shares of common stock and warrants to purchase 198,984 shares of common stock owned by VHCP Co-Investment Holdings, LLC. VHCP Management, LLC is the general partner of Venrock Healthcare Capital Partners, L.P. and the manager of VHCP Co-Investment Holdings, LLC. This represents the number of shares of the Issuer’s common stock beneficially owned as of December 31, 2010. Between December 31, 2010 and the date of the filing of this Schedule 13G/A, Venrock Healthcare Capital Partners, L.P. and VHCP Co-Investment Holdings, LLC have acquired additional shares of the Issuer’s common stock. As of the date of the filing of this Schedule 13G/A, the Reporting Persons beneficially own an aggregate of 5,189,934 shares of the Issuer’s common stock, representing 10.6% of the outstanding shares.
3       This percentage is calculated based upon 49,125,545 shares of the Issuer’s common stock outstanding as of October 29, 2010, as set forth in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 1, 2010.

Page 6 of 12


 

Introductory Note: This Statement on Schedule 13G/A is filed on behalf of Venrock Healthcare Capital Partners, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP LP”), VHCP Co-Investment Holdings, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Investment”), VHCP Management, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management” and collectively with VHCP LP and VHCP Co-Investment, the “Venrock Entities”), Anders Hove and Bryan Roberts in respect of Common Stock of Chelsea Therapeutics International, Ltd.
Item 1.
  (a)   Name of Issuer
Chelsea Therapeutics International, Ltd.
 
  (b)   Address of Issuer’s Principal Executive Offices
3530 Toringdon Way, Suite 200
Charlotte, North Carolina 28277
Item 2.
  (a)   Name of Person Filing
Venrock Healthcare Capital Partners, L.P.
VHCP Co-Investment Holdings, LLC
VHCP Management, LLC
Anders Hove
Bryan Roberts
 
  (b)   Address of Principal Business Office or, if none, Residence
         
New York Office:
  Palo Alto Office:   Cambridge Office:
530 Fifth Avenue
  3340 Hillview Avenue   55 Cambridge Parkway
22nd Floor
  Palo Alto, CA 94304   Suite 100
New York, NY 10036
      Cambridge, MA 02142
  (c)   Citizenship
All entities were organized in Delaware. The individuals are all United States citizens.
 
  (d)   Title of Class of Securities
Common Stock
 
  (e)   CUSIP Number
163428105
Item 3. If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
     Not applicable

Page 7 of 12


 

Item 4. Ownership
  (a)   Amount Beneficially Owned as of December 31, 2010:
         
Venrock Healthcare Capital Partners, L.P.
    4,864,234 (1)
VHCP Co-Investment Holdings, LLC
    4,864,234 (1)
VHCP Management, LLC
    4,864,234 (1)
Anders Hove
    4,864,234 (1)
Bryan Roberts
    4,864,234 (1)
     Percent of Class:
         
Venrock Healthcare Capital Partners, L.P.
    9.9 %
VHCP Co-Investment Holdings, LLC
    9.9 %
VHCP Management, LLC
    9.9 %
Anders Hove
    9.9 %
Bryan Roberts
    9.9 %
    Number of shares as to which the person has:
  (i)   Sole power to vote or to direct the vote
         
Venrock Healthcare Capital Partners, L.P.
    0
VHCP Co-Investment Holdings, LLC
    0
VHCP Management, LLC
    0  
Anders Hove
    0  
Bryan Roberts
    0  
  (ii)   Shared power to vote or to direct the vote
         
Venrock Healthcare Capital Partners, L.P.
    4,864,234 (1)
VHCP Co-Investment Holdings, LLC
    4,864,234 (1)
VHCP Management, LLC
    4,864,234 (1)
Anders Hove
    4,864,234 (1)
Bryan Roberts
    4,864,234 (1)

Page 8 of 12


 

  (iii)   Sole power to dispose or to direct the disposition of
         
Venrock Healthcare Capital Partners, L.P.
    0
VHCP Co-Investment Holdings, LLC
    0
VHCP Management, LLC
    0  
Anders Hove
    0  
Bryan Roberts
    0  
  (iv)   Shared power to dispose or to direct the disposition of
         
Venrock Healthcare Capital Partners, L.P.
    4,864,234 (1)
VHCP Co-Investment Holdings, LLC
    4,864,234 (1)
VHCP Management, LLC
    4,864,234 (1)
Anders Hove
    4,864,234 (1)
Bryan Roberts
    4,864,234 (1)
 
(1)   These shares are owned directly as follows: 4,112,033 shares by Venrock Healthcare Capital Partners, L.P.; and 752,201 by VHCP Co-Investment Holdings, LLC. VHCP Management, LLC is the general partner of Venrock Healthcare Capital Partners, L.P. and the manager of VHCP Co-Investment Holdings, LLC. Messrs. Hove and Roberts are the managing members of VHCP Management, LLC.
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.
Item 6. Ownership of More than Five Percent on Behalf of Another Person
     Not Applicable
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
     Not Applicable
Item 8. Identification and Classification of Members of the Group
The identities of each of the Venrock Entities and Messrs. Hove and Roberts are stated in Item 2(a).
Item 9. Notice of Dissolution of a Group
     Not Applicable
Item 10. Certification
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Page 9 of 12


 

SIGNATURE
     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 14, 2011
                 
Venrock Healthcare Capital Partners, L.P.   VHCP Co-Investment Holdings, LLC    
 
               
By:
  VHCP Management, LLC,   By:   VHCP Management, LLC,    
 
  its General Partner       its Manager    
 
               
By:
  /s/ David L. Stepp
 
Name: David L. Stepp
  By:   /s/ David L. Stepp
 
Name: David L. Stepp
   
 
  Title: Authorized Signatory       Title: Authorized Signatory    
 
               
VHCP Management, LLC            
 
               
By:
  /s/ David L. Stepp            
 
               
 
  Name: David L. Stepp            
 
  Title: Authorized Signatory            
 
               
/s/ David L. Stepp, as attorney-in-fact            
             
Anders Hove            
 
               
/s/ David L. Stepp, as attorney-in-fact            
             
Bryan Roberts            

Page 10 of 12


 

EXHIBITS
A:   Joint Filing Agreement
 
B:   Power of Attorney for Anders Hove (Incorporated by reference from Exhibit B to Schedule 13G filed on March 15, 2010.)
 
C:   Power of Attorney for Bryan Roberts (Incorporated by reference from Exhibit C to Schedule 13G filed on March 15, 2010.)

Page 11 of 12


 

EXHIBIT A
JOINT FILING AGREEMENT
     In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G/A (including amendments thereto) with respect to the Common Stock of Chelsea Therapeutics International, Ltd. and further agree that this agreement be included as an exhibit to such filing. Each party to the agreement expressly authorizes each other party to file on its behalf any and all amendments to such statement. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts.
     In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 14th day of February, 2011.
                 
Venrock Healthcare Capital Partners, L.P.   VHCP Co-Investment Holdings, LLC    
 
               
By:
  VHCP Management, LLC,   By:   VHCP Management, LLC,    
 
  its General Partner       its Manager    
 
               
By:
  /s/ David L. Stepp
 
Name: David L. Stepp
  By:   /s/ David L. Stepp
 
Name: David L. Stepp
   
 
  Title: Authorized Signatory       Title: Authorized Signatory    
 
               
VHCP Management, LLC            
 
               
By:
  /s/ David L. Stepp            
 
               
 
  Name: David L. Stepp            
 
  Title: Authorized Signatory            
 
               
/s/ David L. Stepp, as attorney-in-fact            
             
Anders Hove            
 
               
/s/ David L. Stepp, as attorney-in-fact            
             
Bryan Roberts            

Page 12 of 12

-----END PRIVACY-ENHANCED MESSAGE-----